ArticleNPJ precision oncology2024

Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy.

Charlotte S Walmsley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.